Immunoblotting experiments validated our proteomic analyses, as both total and phosphorylated tau were increased in the sarkosyl-insoluble (aggregated) fractions from the hippocampus (Figure 2D) and cerebral cortex (Figure 3A) of CKD mice. This evidence concerns the gene MAPT and chronic kidney disease.